Chronic Obstructive Pulmonary Disease (COPD) is one of the most common lung diseases. COPD alters the person's breathing patterns because of a long term blockage in the airways. COPD refers to two specific diseases of the lungs; chronic broncitis and emphysema.
Chronic bronchitis involves a long-term cough with mucus while emphysema gradually destrots of the lungs over time. Since both Chronic bronchitis and Emphysema are caused by the same factors, the patient is often diagnosed with both disorders at once.
Chronic obstructive pulmonary disease (COPD) is the third most deadly disease in the U.S. It appears to be partly driven by the action of immune cells circulating in the blood entering into the tissues of the lungs. UC Davis scientists have discovered that this key process begins in the blood vessels around the large airways in the center of the lung. The discovery helps clarify how smoking can bring about this severe respiratory condition.
The research also identifies a potential new target for directed drug therapy to counter the disease, which kills about three million people a year in the U.S. The study is published online today in the Public Library of Science (PLoS) an open-access public science journal.
"Understanding how a disease begins an important step to develop new therapies, and knowing the mechanism and location of white blood cell recruitment to the lung early on in the development of COPD in this model will allow us to more rapidly screen drugs and determine how they work," said Benjamin Davis, a researcher with the Center for Health and the Environment and the lead study author.
"We are currently testing whether statin drugs that may prevent the development of COPD in this model. The model appears to be ideal for screening drugs to treat early COPD, but the ultimate test comes when a treatment is transitioned from the lab to COPD patients," Davis said. "Our primary goal is to save lives."
Chronic bronchitis involves a long-term cough with mucus while emphysema gradually destrots of the lungs over time. Since both Chronic bronchitis and Emphysema are caused by the same factors, the patient is often diagnosed with both disorders at once.
Chronic obstructive pulmonary disease (COPD) is the third most deadly disease in the U.S. It appears to be partly driven by the action of immune cells circulating in the blood entering into the tissues of the lungs. UC Davis scientists have discovered that this key process begins in the blood vessels around the large airways in the center of the lung. The discovery helps clarify how smoking can bring about this severe respiratory condition.
The research also identifies a potential new target for directed drug therapy to counter the disease, which kills about three million people a year in the U.S. The study is published online today in the Public Library of Science (PLoS) an open-access public science journal.
"Understanding how a disease begins an important step to develop new therapies, and knowing the mechanism and location of white blood cell recruitment to the lung early on in the development of COPD in this model will allow us to more rapidly screen drugs and determine how they work," said Benjamin Davis, a researcher with the Center for Health and the Environment and the lead study author.
"We are currently testing whether statin drugs that may prevent the development of COPD in this model. The model appears to be ideal for screening drugs to treat early COPD, but the ultimate test comes when a treatment is transitioned from the lab to COPD patients," Davis said. "Our primary goal is to save lives."



